Jim Cramer, the host of Mad Money, discussed the upcoming market and corporate activity to look forward to this week, which will be dominated by earnings reports from various ...
Keep Reading →
February 3 - Hedge Funds, News
As the DeepSeek craze ignites a sell-off in the tech sector, investors are weighing the implications of the downturn in the long term.
Keep Reading →
January 31 - Hedge Funds, News
On the day that Wall Street's favorite AI GPU stock bled 17% in the wake of investors panicking about Chinese AI startup DeepSeek's low development costs for AI, Jim Cramer had...
Keep Reading →
January 29 - News
Blue chip stocks have long been considered the gold standard of investments, offering a combination of steady growth, consistent dividends, and a reputation for weathering economic...
Keep Reading →
January 29 - Hedge Funds, News
The US stock market is often regarded as one of the most reliable and resilient financial markets in the world.
Keep Reading →
January 28 - Hedge Funds, News
Dividend stocks, while popular among investors, have been underperforming for a while.
Keep Reading →
January 21 - Dividend Stocks, Hedge Funds, News
Dividend stocks have been investors’ favorites for a long time now. Over the years, these equities have performed better than the broader market.
Keep Reading →
January 20 - Dividend Stocks, Hedge Funds, News
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad.
Keep Reading →
January 20 - News, Stock Analysis
In a recent appearance on CNBC's Squawk on the Street, Jim Cramer commented on the devastation ushered in by the California wildfire calamity, social media CEO Mark Zuckerberg...
Keep Reading →
January 18 - News
The U.S. consumer prices report released this week revealed a less-than-expected increase in December, signaling a potential cooling in inflation pressures.
Keep Reading →
January 18 - Hedge Funds, News
As retirement approaches, ensuring financial stability becomes increasingly important for investors.
Keep Reading →
January 6 - Dividend Stocks, Hedge Funds, News
The pharmaceutical industry in 2024 faced a relatively quiet year, with deal volumes similar to 2023 but lower deal values, reflecting a shift toward smaller, more strategic transactions...
Keep Reading →
December 30 - Dividend Stocks, Hedge Funds, News
To select stocks with long-term growth potential, investors should focus on fundamental analysis, evaluating financial health through earnings history, revenue growth, and profit...
Keep Reading →
December 30 - Hedge Funds, News
Jim Cramer, host of Mad Money, recently reflected on how investors often overlook obvious opportunities, particularly with cult stocks, which in hindsight appear to be clear success...
Keep Reading →
December 18 - Hedge Funds, News
As the Federal Reserve exits the year by having continued its interest rate cuts, Wall Street is wondering what 2025 will hold for markets.
Keep Reading →
December 18 - News
Cash remains a critical asset, as companies with strong cash reserves tend to attract investors regardless of the economic climate.
Keep Reading →
December 16 - Dividend Stocks, Hedge Funds, News
Most people have at some point sought to include weight loss and physical exercise in their daily life.
Keep Reading →
December 14 - Hedge Funds, News
The allure of steady income remains a top priority, come rain or shine in the market and for that, investors often prioritize stable companies.
Keep Reading →
December 12 - Dividend Stocks, Hedge Funds, News
Income investors are drawn to Dividend Aristocrats because these stocks have consistently increased their dividends for decades.
Keep Reading →
December 2 - Dividend Stocks, Hedge Funds, News
The global immunotherapy drugs market is rapidly expanding, with projections to grow from $240 billion in 2023 to $1.3 trillion by 2033.
Keep Reading →
November 18 - Hedge Funds, News
Dividend stocks have long been favored by investors for the income they generate, and they become even more appealing when dividends increase over time.
Keep Reading →
November 12 - Dividend Stocks, Hedge Funds, News
Healthcare takes the concept of 'defensive' further than almost any industry, encompassing many companies that provide patient care, engage in the research and development of ...
Keep Reading →
November 4 - Hedge Funds, Industries, News
Bristol-Myers Squibb Company (NYSE:BMY) Q3 2024 Earnings Call Transcript October 31, 2024Bristol-Myers Squibb Company beats earnings expectations.
Keep Reading →
November 1 - News, Transcripts
Jim Cramer, the host of Mad Money, recently advised investors to maintain composure as major companies release their earnings this week.
Keep Reading →
October 29 - Hedge Funds, News
We came across a bullish thesis on Bristol-Myers Squibb Company (BMY) on Disruptive analytics’ Substack by Magnus Ofstad.
Keep Reading →
October 17 - News, Stock Analysis
The medical and healthcare industry is one of the largest globally, with a steady demand for products and services due to the biological nature of humans.
Keep Reading →
October 15 - News
“In a market with huge year-to-date gains, you got to get a little more selective about what you buy.
Keep Reading →
October 14 - Hedge Funds, News
The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are expected to see GDP boosts of 26% and 14.5%, respectively...
Keep Reading →
October 5 - Hedge Funds, Industries, News, Tech
Dividend investing has become increasingly popular over time, as generating regular income remains a key focus for investors.
Keep Reading →
September 27 - Dividend Stocks, Hedge Funds, News
Short sellers have faced significant challenges over the past few years, as the market's ongoing rally has not been favorable to them, with 2023 being no exception.
Keep Reading →
September 24 - Dividend Stocks, Hedge Funds, News
Dividend stocks have faced challenges over the past year due to the rising focus on tech stocks.
Keep Reading →
September 4 - Dividend Stocks, Hedge Funds, News
Bristol-Myers Squibb Company (NYSE:BMY) Q2 2024 Earnings Call Transcript July 26, 2024Bristol-Myers Squibb Company beats earnings expectations.
Keep Reading →
July 27 - News, Transcripts
We recently published the list of 11 stocks Jim Cramer is bearish on. Bristol-Myers Squibb Co (NYSE:BMY) ranks 2nd in the list.
Keep Reading →
June 5 - Hedge Funds, News
Jim Cramer in a latest program said the "bulls" want the economy to slow down, they want rate cuts as well as a strong demand so that "their companies" won't have to worry about...
Keep Reading →
June 5 - Hedge Funds, News
Bristol-Myers Squibb Company beats earnings expectations. Reported EPS is $-4.4, expectations were $-4.55.
Keep Reading →
April 30 - News, Transcripts
In this piece, we will take a look at the five best weight loss drug stocks to buy now.
Keep Reading →
April 6 - Hedge Funds, News
Ariel Investments, an investment management company, released its “Ariel Global Fund” fourth-quarter 2023 investor letter. A copy of the same can be downloaded here.
Keep Reading →
March 25 - Hedge Fund Investor Letters, News
In this article, we discuss 5 52-week low dividend stocks to consider.
Keep Reading →
March 19 - Dividend Stocks, Hedge Funds, News
In this article, we discuss 5 best high-dividend stocks to buy right now.
Keep Reading →
March 14 - News
In this piece, we will take a look at the five most profitable biotech stocks to invest in.
Keep Reading →
March 14 - News, Quantitative Investing
In this article, we will discuss the 10 stocks recently downgraded by analysts.
Keep Reading →
March 13 - Market Movers, News
In this article, we discuss 13 best pharma dividend stocks to buy in 2024.
Keep Reading →
March 5 - Dividend Stocks, Hedge Funds, News
Aristotle Atlantic Partners, LLC, an investment management company, released its “Core Equity Strategy” fourth quarter 2023 investor letter.
Keep Reading →
March 4 - Hedge Fund Investor Letters, News
This article presents an overview of the 5 Best Stocks to Buy Before US Election Season 2024.
Keep Reading →
February 24 - Hedge Funds, News
In this article, we discuss 16 best income stocks to buy according to analysts.
Keep Reading →
February 18 - Dividend Stocks, Hedge Funds, News
In this article, we will take a look at the 30 most valuable drug companies in 2024.
Keep Reading →
February 10 - Business, Industries, Lists, News
In this article, we discuss 10 dividend stocks that are on sale 30% or more.
Keep Reading →
February 6 - Dividend Stocks, Hedge Funds, News
Operator: Welcome to the Bristol-Myers Squibb Fourth Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.
Keep Reading →
February 3 - News, Transcripts
In this piece, we will take a look at five blue chip stocks at 52 week lows.
Keep Reading →
February 2 - News
In this article, we discuss the 15 best low cost stocks to buy under $75.
Keep Reading →
January 31 - Hedge Funds, News